Cat. No. ARC1036
OVSAHO is a human ovarian carcinoma cell line established from the abdominal metastatic tumor of a 56-year-old female with serous papillary adenocarcinoma. OVSAHO expresses several cytokeratins (CKs) peptides. OVSAHO cells are transplantable in both nude and immune-competent mice for intraperitoneal, subcutaneous, and orthotopic heterotransplantation. <br> <br>OVSAHO cells and their xenograft models are used as experimental platform for studying high-grade serous adenocarcinoma (HGSOC). HGSOC grows rapidly and spread early to other tissues within the peritoneal cavity, and is therefore regarded as one of the most lethal forms of human ovarian cancer. The OVSAHO cells are used to develop strategies for early diagnosis and to screen potential anticancer agents targeting HGSOC.
| Sex of Donor | Female |
| Age | 56 years |
| Derived From Site | Metastatic; Abdomen |
| Morphology | Epithelial-like |
| Growth Mode | Adherent |
| Temperature | 37°C |
| Atmosphere | 5% CO₂ |
| Sterility testing | The bacterial, yeast, and fungi are not detected in these cells by daily monitor. |
| Mycoplasma testing | Negative for mycoplasma through PCR analysis |
Intended Use: This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer: Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use.
This product is provided "AS IS". For Research Use Only. Not for human or animal therapeutic use.